Should I Buy BIIB Stock in 2026?
Data-driven analysis and honest assessment for Biogen Inc
Current Price: $185.63P/E: 17.1
Decision Score
Hold
Based on 6 fundamental factors
Score Breakdown:
Reasonable P/E of 17.1
Slow growth of 0%
Thin margins (0% net)
Financial health data limited
Excellent FCF yield of 8.7%
No recent insider activity
Key Investment Metrics
Current Price
$185.63
P/E Ratio
17.09
Revenue Growth
0.0%
Profit Margin
0.2%
Market Cap
$27.5B
Dividend Yield
None
How BIIB Compares to Competitors
Understanding how BIIB stacks up against peers helps inform your investment decision.
How BIIB Compares to Peers
Upcoming Events for BIIB
+5 Reasons TO Buy BIIB
1. High gross margins of 77%
strongGross margins above 50% typically indicate strong brand value or intellectual property moats.
2. High free cash flow yield of 8.7%
strongFCF yield above 5% means substantial cash generation for dividends, buybacks, or reinvestment.
-5 Reasons NOT to Buy BIIB
1. Thin profit margins of 0.2%
high riskLow margins provide little cushion against cost increases or pricing pressure.
2. High PEG ratio of 5.4
high riskPEG above 2 suggests expensive relative to growth rate.
3. Minimal revenue growth
low riskGrowth of 0.0% barely keeps pace with inflation.
Who Should Buy BIIB?
Investment Profile
Risk Level
Medium
Recommended Holding Period
3-5 years
Best For:
- ✓
Value Investors
P/E of 17.1 offers margin of safety
Not Suitable For:
- ✗
Growth Investors
Limited 0% growth may disappoint
- ✗
Income-Focused Retirees
No dividend paid
Consider These Alternatives
If you're interested in BIIB, compare these Healthcare peers:
Pro tip: Compare BIIB directly with competitors using our comparison tool to see which stock better fits your criteria.
Get the Full Picture
Access AI-powered insights, DCF valuations, insider trading data, and real-time analysis for BIIB
Frequently Asked Questions
What is BIIB stock price today?
BIIB (Biogen Inc) stock is trading at $185.63 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).
Is BIIB stock going up or down today?
BIIB stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.
Should I buy BIIB stock now?
The decision to buy BIIB depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.
Is BIIB a buy, hold, or sell right now?
Our AI-powered analysis provides buy/hold/sell recommendations for BIIB based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.
Is BIIB stock overvalued or undervalued?
BIIB currently trades at a P/E ratio of 17.09 relative to earnings. Our DCF calculator provides intrinsic value estimates to help determine if BIIB is fairly priced.
What is BIIB's P/E ratio?
BIIB has a price-to-earnings (P/E) ratio of 17.09, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.
What is BIIB's market cap?
BIIB (Biogen Inc) has a market capitalization of $27.52 billion, making it a mid-cap stock.
What is BIIB's price to book ratio?
BIIB trades at a price-to-book (P/B) ratio of 1.51, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.
Deep Dive Analysis
Explore comprehensive analysis tools to make an informed decision about Biogen Inc
Full Stock Analysis
Complete BIIB overview with charts and data
Is BIIB Undervalued?
DCF valuation and intrinsic value analysis
Dividend Analysis
Yield, payout ratio, and dividend history
Growth Analysis
Revenue, earnings, and expansion metrics
Financial Health
Debt, liquidity, and balance sheet strength
Price Prediction
2026 forecast and price targets
Stock Forecast
12-month price forecast and analyst targets
Earnings Date
Next earnings date and historical results
Compare Before You Buy
See how BIIB stacks up against its competitors
Similar Investment Decisions
Explore investment analyses for stocks similar to Biogen Inc
Complete BIIB Analysis
Compare BIIB With
Disclaimer
This analysis is for informational purposes only and should not be considered financial advice. The decision score and recommendations are based on quantitative factors and do not account for all risks, your personal financial situation, or qualitative factors. Always do your own research and consider consulting with a financial advisor before making investment decisions.